Back to BCRX
PRINCIPAL FINANCIAL GROUP INC → BCRX
PRINCIPAL FINANCIAL GROUP INC BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
10
Latest value
$216K
Q3 2026
Peak value
$5.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $122K |
| Q3 2025 | $1.7M |
| Q4 2025 | $97K |
| Q4 2025 | $2.8M |
| Q1 2026 | $3.9M |
| Q1 2026 | $150K |
| Q2 2026 | $178K |
| Q2 2026 | $4.5M |
| Q3 2026 | $5.7M |
| Q3 2026 | $216K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $216K | 25.9K | — | — |
| Q3 2026 | $5.7M | 689.9K | — | — |
| Q2 2026 | $4.5M | 451.0K | — | — |
| Q2 2026 | $178K | 17.8K | — | — |
| Q1 2026 | $150K | 15.8K | — | — |
| Q1 2026 | $3.9M | 414.8K | — | — |
| Q4 2025 | $2.8M | 364.2K | — | — |
| Q4 2025 | $97K | 12.4K | — | — |
| Q3 2025 | $1.7M | 228.4K | — | — |
| Q3 2025 | $122K | 16.0K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M